Weight-loss medicines and hair loss: New study finds genetic link in men
6 Articles
6 Articles
New light on one of the most feared side effects of the new anti-obesity drugs, the GLP-1 such as Ozempic, Wegovy and Zepbound: hair loss. If so far the thinning of the hair was attributed only to the rapid weight loss linked to the use of these molecules, a research conducted by NYU Langone Health demonstrates the existence of a real and [...] The article "First was only a suspicion, now there is confirmation. Ozempic, Wegovy and the slimming d…
The investigation detects 7% more risk in men with genetic predisposition Traffic cuts through La Vuelta between El Puerto and Jerez: Timetables and cut streets
Weight-loss medicines and hair loss: New study finds genetic link in men
NEW YORK (ANI): Weight-loss drugs such as Ozempic, Wegovy and Zepbound may be linked to a higher risk of male-pattern hair loss, with men already genetically predisposed to the condition facing a seven per cent additional risk, according to a new study led by researchers at NYU Langone Health.
Ozempic, Wegovy, Zepbound drugs linked to higher hair loss risk in men, a new Study - The Canadian Media
IBNS-CMEDIA: Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like Ozempic, Wegovy, and Zepbound for type 2 diabetes and obesity, a new study shows. Led by researchers at NYU Langone Health, the study focused on the
New York: There are many people taking weight loss pills these days. However, taking such pills not only leads to weight loss, but also increases the risk of hair loss in men...
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
